2.1 Healthcare Personnel Immunizations and Health Screening

Healthcare Personnel Immunization and Screening

An occupational-health program protects personnel and patients through vaccination, documented immune status when recommended, baseline screening, exposure management, and confidential records. The Infection Control Coordinator supports the system, but individual medical decisions belong to occupational-health clinicians using current CDC and ACIP guidance.

Hepatitis B: Employer Duties and Immune Response

Under OSHA’s Bloodborne Pathogens Standard, an employer must make hepatitis B vaccination available at no cost to covered employees with occupational exposure, at a reasonable time and place, and within 10 working days of initial assignment after required training. An employee may decline using OSHA’s statement and later accept the vaccine at employer expense.

Current U.S. single-antigen adult products include a two-dose Heplisav-B series at least four weeks apart and three-dose Engerix-B or Recombivax HB schedules. Follow the current ACIP schedule and product labeling rather than a memorized brand list. PreHevbrio was voluntarily withdrawn from the U.S. market; remaining doses should not be used.

For healthcare personnel at risk for blood exposure, obtain quantitative anti-HBs 1–2 months after the final dose. An anti-HBs result of at least 10 mIU/mL after a documented complete series establishes response. Immunocompetent responders do not need periodic titers or routine boosters. Testing HBsAg evaluates current infection; anti-HBc indicates prior or current natural infection, not vaccine response.

If anti-HBs is below 10 mIU/mL after the initial complete series, revaccinate under current CDC guidance and retest 1–2 months after the final dose. A person whose anti-HBs remains below 10 after two complete series is a documented nonresponder and should be tested and counseled for susceptibility and possible infection. Do not simply give endless vaccine series.

Postexposure management depends on the worker’s documented vaccination/response and the source patient’s HBsAg result. A documented nonresponder after two complete series receives two doses of HBIG one month apart if the source is HBsAg-positive or unknown, and no HBIG if the source is HBsAg-negative. Give the first indicated dose as soon as possible. Other response categories use the current CDC table; do not apply HBIG to every exposure.

Current occupational guidance estimates average transmission after percutaneous exposure at about 0.2% for HCV and 0.23% for HIV. HBV risk is much higher in a susceptible worker when the source has high viral replication. Vaccination and documented response make HBV the preventable member of that comparison.

Other Vaccines for Dental Personnel

Use the current ACIP recommendations for healthcare personnel and the worker’s age, history, pregnancy status, and health conditions:

• Influenza: vaccination each season.
• MMR: evidence of immunity or the recommended dose series; healthcare-personnel criteria can differ from general community presumptions.
• Varicella: evidence of immunity or the recommended two-dose series for susceptible personnel.
• Tdap/Td: at least one Tdap dose, pregnancy dosing when applicable, wound management, and boosters under the adult schedule.
• COVID-19 and other respiratory vaccines: follow the current CDC/ACIP schedule rather than embedding a season-specific formulation in a long-lived guide.

Vaccination recommendations are not all OSHA mandates. OSHA specifically governs the employer’s hepatitis B offer for covered occupational exposure; ACIP supplies clinical vaccine recommendations. State law or facility policy may add requirements.

Tuberculosis Screening

Current CDC/NTCA guidance begins with baseline screening when healthcare personnel are hired: an individual TB risk assessment, symptom evaluation, and a TB test for people without documented prior TB disease or latent infection. Use an IGRA or TST. If a TST is selected for baseline testing, two-step testing may be needed: read the first test 48–72 hours after placement and, if negative, place the second 1–3 weeks later.

Routine annual testing is not recommended after baseline unless there is a known exposure or ongoing transmission in the setting. Facilities still provide annual TB education and symptom awareness as their risk assessment requires. After an unprotected exposure, promptly perform symptom evaluation and initial testing when indicated, then repeat a negative test 8–10 weeks after the last exposure. Personnel with prior positive tests receive symptom evaluation rather than repeated infection tests.

Symptoms that can suggest active TB include persistent cough, hemoptysis, fever, night sweats, weight loss, fatigue, and anorexia. No single “three-week cough” rule replaces clinical evaluation. A symptomatic or newly positive worker needs prompt occupational-health assessment and is restricted according to current public-health guidance.

For a patient with suspected or confirmed infectious pulmonary or laryngeal TB, defer elective dental care and arrange medical evaluation. If urgent dental care cannot wait, refer to a facility able to provide airborne infection isolation and a respiratory-protection program. The AIIR must meet applicable current ventilation criteria; do not impose one universal ACH or filtration design on every facility.

Confidential Records and Program Review

Keep vaccination, anti-HBs, TB, and exposure records confidential and separate from ordinary personnel files, with access limited as required by OSHA and other applicable law. OSHA medical records for covered occupational exposure are retained for employment plus 30 years. The facility should track completion without displaying private diagnoses to supervisors or coworkers.

Review current CDC/ACIP schedules at least when a product, public-health recommendation, exposure, pregnancy, or medical condition changes. The exam distinction is: OSHA employer duty, ACIP clinical recommendation, documented immune response, and risk-based screening are related but not interchangeable.